Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
AIMS/HYPOTHESIS: The aim of our study was to identify subgroups of patients attending the Scottish Diabetic Retinopathy Screening (DRS) programme who might safely move from annual to two yearly retinopathy screening. METHODS: This was a retrospective cohort study of screening data from the DRS programme collected between 2005 and 2011 for people aged ≥12 years with type 1 or type 2 diabetes in Scotland. We used hidden Markov models to calculate the probabilities of transitions to referable diabetic retinopathy (referable background or proliferative retinopathy) or referable maculopathy. RESULTS: The study included 155,114 individuals with no referable diabetic retinopathy or maculopathy at their first DRS examination and with one or more further DRS examinations. There were 11,275 incident cases of referable diabetic eye disease (9,204 referable maculopathy, 2,071 referable background or proliferative retinopathy). The observed transitions to referable background or proliferative retinopathy were lower for people with no visible retinopathy vs mild background retinopathy at their prior examination (respectively, 1.2% vs 8.1% for type 1 diabetes and 0.6% vs 5.1% for type 2 diabetes). The lowest probability for transitioning to referable background or proliferative retinopathy was among people with two consecutive screens showing no visible retinopathy, where the probability was <0.3% for type 1 and <0.2% for type 2 diabetes at 2 years. CONCLUSIONS/INTERPRETATION: Transition rates to referable diabetic eye disease were lowest among people with type 2 diabetes and two consecutive screens showing no visible retinopathy. If such people had been offered two yearly screening the DRS service would have needed to screen 40% fewer people in 2009.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Artificial intelligence approaches to screening for diabetic retinopathy have progressed to the point of utility and cost-effectiveness.508–513”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [511]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
(2007) · Developments in Ophthalmology · doi:10.1159/isbn.978-3-318-01439-6 · Cited by 5,583
Elman, M. J., Aiello, L. P., Beck, R. W., Bressler, N. M., Bressler, S. B., Edwards, A. R., Ferris, F. L., Friedman, S. M., Glassman, A. R., Miller, K. M., et al. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2010.02.031 · Cited by 1,428
Mitchell, P., Bandello, F., Schmidt-Erfurth, U., Lang, G. E., Massin, P., Schlingemann, R. O., Sutter, F., Simader, C., Burian, G., Gerstner, O., et al. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.01.031 · Cited by 1,326
Multi-State Models for Panel Data: The msm Package for R
Jackson, C. H. (2011) · Journal of Statistical Software · doi:10.18637/jss.v038.i08 · Cited by 1,297
Livingstone, S. J., Looker, H. C., Hothersall, E. J., Wild, S. H., Lindsay, R. S., Chalmers, J., Cleland, S., Leese, G. P., McKnight, J., Morris, A. D., et al. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001321 · Cited by 345
Self-citationYounis, N., Broadbent, D. M., Vora, J. P., & Harding, S. P. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12267-2 · Cited by 289
Aspelund, T., Þórisdóttir, Ó., Ólafsdottir, E., Gudmundsdottir, A., Einarsdóttir, A. B., Mehlsen, J., Einarsson, S., Pálsson, Ó., Einarsson, G., Bek, T., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2257-7 · Cited by 167
Jones, C. D., Greenwood, R. H., Misra, A., & Bachmann, M. O. (2012) · Diabetes Care · doi:10.2337/dc11-0943 · Cited by 150
Thomas, R. L., Dunstan, F., Luzio, S. D., Roy Chowdury, S., Hale, S. L., North, R. V., Gibbins, R. L., & Owens, D. R. (2012) · BMJ · doi:10.1136/bmj.e874 · Cited by 142
Agardh, E., & Tababat-Khani, P. (2011) · Diabetes Care · doi:10.2337/dc10-2308 · Cited by 113 · cited 1×
“Iceland [8] and Sweden [9] have both reported on their positive experiences of switching individuals without evidence of retinopathy to longer screening intervals.”
BackgroundDiabetic retinopathy at diagnosis of type 2 diabetes in Scotland
on behalf of the Scottish Diabetic Retinopathy Screening Collaborative and the Scottish Diabetes Research Network Epidemiology Group, Looker, H. C., Nyangoma, S. O., Cromie, D., Olson, J. A., Leese, G. P., Black, M., Doig, J., Lee, N., Lindsay, R. S., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2596-z · Cited by 110
Self-citationBiennial eye screening in patients with diabetes without retinopathy: 10-year experience
Olafsdottir, E., & Stefansson, E. (2007) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.123810 · Cited by 105
Incidence of sight‐threatening retinopathy in Type 1 diabetes in a systematic screening programme
Younis, N., Broadbent, D. M., Harding, S. P., & Vora, J. P. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.01035.x · Cited by 103
KOHNER, E. M. (1993) · BMJ · doi:10.1136/bmj.307.6913.1195 · Cited by 73
Philip, S., Cowie, L. M., & Olson, J. A. (2005) · British Journal of Ophthalmology · doi:10.1136/bjo.2004.051334 · Cited by 65
Self-citationIndividualized optimization of the screening interval for diabetic retinopathy: a new model
Mehlsen, J., Erlandsen, M., Poulsen, P. L., & Bek, T. (2010) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2010.01882.x · Cited by 53
Chalk, D., Pitt, M., Vaidya, B., & Stein, K. (2012) · Diabetes Care · doi:10.2337/dc11-2282 · Cited by 48
Leese, G. P., Morris, A. D., Swaminathan, K., Petrie, J. R., Sinharay, R., Ellingford, A., Taylor, A., Jung, R. T., Newton, R. W., & Ellis, J. D. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01603.x · Cited by 38
Self-citationJones, C. D., Greenwood, R. H., Misra, A., & Bachmann, M. O. (2014) · Diabetes Care · doi:10.2337/dc14-er03a · Cited by 31
Goatman, K. A., Philip, S., Fleming, A., Harvey, R. D., Swa, K., Styles, C., Black, M. W., Sell, G., Lee, N., Sharp, P. F., et al. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03504.x · Cited by 20
Self-citation
Research works printed but not linked: 1
- Facey K Cummins E Macpherson K Morris K Reay L Slattery J Organisation of services for diabetic retinopathy screening 2002 Glasgow Health Technology Assessment Report 1. Health Technology Board for Scotland
Cited by
The progress in understanding and treatment of diabetic retinopathy
Stitt, A. W., Curtis, T. M., Chen, M., Medina, R. J., McKay, G. J., Jenkins, A., Gardiner, T. A., Lyons, T. J., Hammes, H.-P., Simó, R., et al. (2016) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.08.001 · Cited by 1,164
Screening for diabetic retinopathy: new perspectives and challenges
Vujosevic, S., Aldington, S. J., Silva, P., Hernández, C., Scanlon, P., Peto, T., & Simó, R. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30411-5 · Cited by 671
“[17-20] + (Diabetic Medicine (2019:36;1199-1208).”
Handelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S., et al. (2015) · Endocrine Practice · doi:10.4158/ep15672.gl · Cited by 629
The changing face of diabetes complications
Gregg, E. W., Sattar, N., & Ali, M. K. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30010-9 · Cited by 612
Self-citationHandelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S., et al. (2015) · Endocrine Practice · doi:10.4158/ep15672.glsuppl · Cited by 559
Metadata
- Authors
- on behalf of the Scottish Diabetes Research Network (SDRN) Epidemiology Group and the Scottish Diabetic Retinopathy Collaborative, Looker, H. C., Nyangoma, S. O., Cromie, D. T., Olson, J. A., Leese, G. P., Philip, S., Black, M. W., Doig, J., Lee, N., Briggs, A., Hothersall, E. J., Morris, A. D., Lindsay, R. S., McKnight, J. A., Pearson, D. W. M., Sattar, N. A., Wild, S. H., McKeigue, P., & Colhoun, H. M.
- Affiliations
- University of Dundee (GB)
- NHS Lanarkshire (GB)
- Aberdeen Royal Infirmary (GB)
- Ninewells Hospital (GB)
- NHS Grampian (GB)
- NHS Highland (GB)
- Forth Valley Royal Hospital (GB)
- University of Glasgow (GB)
- Western General Hospital (GB)
- University of Edinburgh (GB)
- Corresponding author
- Looker, H. C.
- ORCID
- Venue
- Diabetologia
- Published
- 2013-05-21
- Volume
- 56
- Issue
- 8
- Pages
- 1716-1725
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- PMC
- PMC3699707
- OpenAlex
- W2082965216
- Cited by
- 80
- References
- 21
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 8 · 2023: 5 · 2022: 4 · 2021: 5 · 2020: 10 · 2019: 2 · 2018: 4 · 2017: 9 · 2016: 7 · 2015: 12 · 2014: 6 · 2013: 2
- FWCI
- 8.86
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetologia (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
- Aberdeen University Research Archive (Aberdeen University) (submittedVersion, other-oa)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by-nc)
- Funders
- Wellcome Trust (/WT086113)
- NHS Health Scotland
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- diabetic retinopathy, screening frequency, type 1 diabetes, type 2 diabetes, referable diabetic retinopathy, proliferative diabetic retinopathy, background retinopathy, hidden Markov models, transition probabilities, screening efficiency
- MeSH terms
- Adult, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diabetic Retinopathy, Female, Humans, Male, Mass Screening, Middle Aged, Retrospective Studies, Scotland, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.